IN2012DN03428A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN03428A IN2012DN03428A IN3428DEN2012A IN2012DN03428A IN 2012DN03428 A IN2012DN03428 A IN 2012DN03428A IN 3428DEN2012 A IN3428DEN2012 A IN 3428DEN2012A IN 2012DN03428 A IN2012DN03428 A IN 2012DN03428A
- Authority
- IN
- India
- Prior art keywords
- pharmaceutical compositions
- nitrites
- compositions
- prodrugs
- formulated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
- A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Zoology (AREA)
- Botany (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25148309P | 2009-10-14 | 2009-10-14 | |
| PCT/US2010/052683 WO2011047161A1 (en) | 2009-10-14 | 2010-10-14 | Pharmaceutical formulations of nitrite and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2012DN03428A true IN2012DN03428A (enExample) | 2015-10-23 |
Family
ID=43855036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3428DEN2012 IN2012DN03428A (enExample) | 2009-10-14 | 2010-10-14 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US10463689B2 (enExample) |
| EP (1) | EP2488035B1 (enExample) |
| JP (3) | JP5758904B2 (enExample) |
| CN (2) | CN102686111A (enExample) |
| AU (1) | AU2010306755B2 (enExample) |
| CA (1) | CA2777066C (enExample) |
| ES (1) | ES2633618T3 (enExample) |
| IL (1) | IL219155A0 (enExample) |
| IN (1) | IN2012DN03428A (enExample) |
| WO (1) | WO2011047161A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101939014B (zh) | 2007-11-15 | 2016-04-27 | 路易斯安那州大学及农业和机械学院管理委员会 | 亚硝酸盐在慢性缺血中的应用 |
| US9241999B2 (en) | 2009-06-15 | 2016-01-26 | Board Of Regents Of The University Of Texas System | Method of producing physiological and therapeutic levels of nitric oxide through an oral delivery system |
| US20120237617A1 (en) | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| IN2012DN03428A (enExample) | 2009-10-14 | 2015-10-23 | Theravasc Inc | |
| US8627204B2 (en) * | 2011-10-18 | 2014-01-07 | Microsoft Corporation | Custom optimization of web pages |
| ES2741146T3 (es) * | 2013-02-20 | 2020-02-10 | The Board Of Supervisors Of The Louisiana State Univ Mechanical And Agricultural College | Formulaciones farmacéuticas de nitrio y sus usos |
| CN105339006A (zh) * | 2013-05-10 | 2016-02-17 | 尼特罗米加公司 | 含有脂肪酸和亚硝酸盐的营养或膳食补充剂 |
| GB201309092D0 (en) | 2013-05-20 | 2013-07-03 | Edixomed Ltd | Transdermal delivery system |
| US20170349438A1 (en) | 2016-06-06 | 2017-12-07 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| US11116731B2 (en) | 2017-02-20 | 2021-09-14 | Brd. of Sup. of LSU and A &M College | Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation |
| US11850271B1 (en) * | 2023-05-16 | 2023-12-26 | King Faisal University | Topical skin cream |
| WO2026006722A1 (en) | 2024-06-28 | 2026-01-02 | The Regents Of The University Of Michigan | Nitric oxide generating medical devices and methods |
Family Cites Families (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2914446A (en) * | 1958-06-26 | 1959-11-24 | Upjohn Co | Nitrite stabilized ascorbic acid-cyanocobalamin compositions |
| US4650484A (en) | 1983-02-03 | 1987-03-17 | Alza Corporation | Method for treating ischemic conditions |
| IE64726B1 (en) | 1987-11-20 | 1995-08-23 | Elan Corp Plc | Pharmaceutical formulations for preventing drug tolerance |
| US5122384A (en) | 1989-05-05 | 1992-06-16 | Kv Pharmaceutical Company | Oral once-per-day organic nitrate formulation which does not induce tolerance |
| US5278192A (en) | 1992-07-02 | 1994-01-11 | The Research Foundation Of State University Of New York | Method of vasodilator therapy for treating a patient with a condition |
| US6709681B2 (en) | 1995-02-17 | 2004-03-23 | Aberdeen University | Acidified nitrite as an antimicrobial agent |
| US20110196039A9 (en) * | 1994-10-05 | 2011-08-11 | Kaesemeyer Wayne H | Controlled release arginine formulations |
| US5648101A (en) * | 1994-11-14 | 1997-07-15 | Tawashi; Rashad | Drug delivery of nitric oxide |
| US5770645A (en) | 1996-08-02 | 1998-06-23 | Duke University Medical Center | Polymers for delivering nitric oxide in vivo |
| US5994444A (en) * | 1997-10-16 | 1999-11-30 | Medtronic, Inc. | Polymeric material that releases nitric oxide |
| US7371415B1 (en) | 1998-04-03 | 2008-05-13 | The Daily Wellness Company | Method and composition for improving sexual fitness |
| US7015876B1 (en) * | 1998-06-03 | 2006-03-21 | Lear Corporation | Heads-up display with improved contrast |
| EP1105146A1 (en) | 1998-07-14 | 2001-06-13 | Paracelsian, Inc. | Method for identifying and confirming consistent bio-functionality of natural compositions |
| EP1146862B1 (de) | 1999-01-29 | 2003-04-23 | Disphar International B.V. | Pharmazeutische zusammensetzungen |
| GB9905425D0 (en) | 1999-03-09 | 1999-05-05 | Queen Mary & Westfield College | Pharmaceutical composition |
| US6314956B1 (en) | 1999-09-08 | 2001-11-13 | Duke University | Pulmonary delivery of NO group-containing compound in gas form to treat respiratory, cardiac and blood disorders |
| GB0119011D0 (en) | 2001-08-03 | 2001-09-26 | Univ Aberdeen | Treatment of nail infections |
| US20030125714A1 (en) | 2001-12-18 | 2003-07-03 | Edgren David Emil | Dosage form for time-varying patterns of drug delivery |
| EP1336602A1 (en) | 2002-02-13 | 2003-08-20 | Giovanni Scaramuzzino | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases |
| US20030219494A1 (en) * | 2002-03-20 | 2003-11-27 | Smith Maree Therese | Compositions and methods of using them |
| CA2379211A1 (fr) | 2002-03-28 | 2003-09-28 | Institut De Cardiologie De Montreal | Utilisation du bleu de methylene pour renverser la reaction hemodynamique exageree induite par la combinaison d'un derive nitre et du sildenafil ou d'une molecule de meme classe (inhibiteur de la phosphodiesterase) |
| AU2004255268B2 (en) | 2003-07-09 | 2010-04-01 | Loma Linda University | Use of nitrite salts for the treatment of cardiovascular conditions |
| WO2005018561A2 (en) | 2003-08-20 | 2005-03-03 | Nitromed, Inc. | Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| WO2005023189A2 (en) | 2003-09-03 | 2005-03-17 | Pharmacia Corporation | Method of cox-2 selective inhibitor and nitric oxide-donating agent |
| US7362274B1 (en) | 2004-07-09 | 2008-04-22 | Huan-Cheng Lien | Coupled feed-in butterfly shaped left/right hand circularly polarized microstrip antenna |
| US20060083824A1 (en) | 2004-10-20 | 2006-04-20 | Pbm Products Llc | Nutritional supplements for glucose intolerant individuals |
| KR20070105331A (ko) | 2005-02-11 | 2007-10-30 | 노랩스 에이비 | 일산화질소를 포함하는 신경병증의 치료 장치, 방법 및용도 |
| EP1883416A4 (en) | 2005-05-24 | 2013-06-12 | Wellgen Inc | COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING CONDITIONS RELATED TO INFLAMMATION |
| MX2008010127A (es) * | 2006-02-10 | 2009-03-05 | Mannatech Inc | Formulaciones de suplementos dieteticos multivitaminicos y multiminerales naturales, para su absorcion mejorada y uso biologico. |
| GB0607402D0 (en) | 2006-04-12 | 2006-05-24 | Barts & London Nhs Trust | Therapeutic composition and use |
| WO2007149520A2 (en) | 2006-06-21 | 2007-12-27 | Albert Einstein College Of Medicine Of Yeshiva University | Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof |
| EP3159000B1 (en) | 2007-02-26 | 2025-05-21 | HeartBeet Ltd. | Performance enhancing composition |
| KR20100014853A (ko) | 2007-02-26 | 2010-02-11 | 존 런드버그 | 아질산염 및 질산염의 신규 용도 및 이를 함유하는 조성물 |
| WO2008153762A2 (en) | 2007-05-25 | 2008-12-18 | N30 Pharmaceuticals, Llc | S-nitrosothiol formulations and storage systems |
| EP2184986A4 (en) * | 2007-08-06 | 2010-12-15 | Trinity Lab Inc | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHRONIC PAIN AND PAIN RELATING TO NEUROPATHY |
| CN101939014B (zh) | 2007-11-15 | 2016-04-27 | 路易斯安那州大学及农业和机械学院管理委员会 | 亚硝酸盐在慢性缺血中的应用 |
| JP2011507968A (ja) * | 2007-12-27 | 2011-03-10 | エイヤーズ ファーマシューティカルズ、インク． | エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用 |
| WO2010036236A1 (en) | 2008-09-23 | 2010-04-01 | Baker Hughes Incorporated | Anchor assembly |
| US8568793B2 (en) * | 2009-02-11 | 2013-10-29 | Hope Medical Enterprises, Inc. | Sodium nitrite-containing pharmaceutical compositions |
| US20120237617A1 (en) | 2009-06-18 | 2012-09-20 | Theravasc Inc. | Use of nitrite salts in treating tissue damage |
| IN2012DN03428A (enExample) * | 2009-10-14 | 2015-10-23 | Theravasc Inc | |
| US20130209584A1 (en) | 2009-10-14 | 2013-08-15 | Theravasc Inc. | Pharmaceutical formulations of nitrite and uses thereof |
| US20140127329A1 (en) | 2011-03-31 | 2014-05-08 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | Use of nitrites for the treatment of cerebral amyloid angiopathy, age associated dementia, and cognitive decline |
| US20140112983A1 (en) | 2011-04-14 | 2014-04-24 | Theravasc Inc. | Nitrite compositions and uses thereof |
| US9294956B2 (en) | 2011-12-29 | 2016-03-22 | Qualcomm Incorporated | Application-server-assisted preemptive multicast bearer establishment for real-time low-latency applications |
-
2010
- 2010-10-14 IN IN3428DEN2012 patent/IN2012DN03428A/en unknown
- 2010-10-14 EP EP10824097.9A patent/EP2488035B1/en active Active
- 2010-10-14 ES ES10824097.9T patent/ES2633618T3/es active Active
- 2010-10-14 JP JP2012534359A patent/JP5758904B2/ja active Active
- 2010-10-14 US US12/904,791 patent/US10463689B2/en active Active
- 2010-10-14 AU AU2010306755A patent/AU2010306755B2/en not_active Ceased
- 2010-10-14 CN CN2010800568984A patent/CN102686111A/zh active Pending
- 2010-10-14 CA CA2777066A patent/CA2777066C/en active Active
- 2010-10-14 WO PCT/US2010/052683 patent/WO2011047161A1/en not_active Ceased
- 2010-10-14 CN CN201710462544.3A patent/CN107260756A/zh active Pending
-
2012
- 2012-04-15 IL IL219155A patent/IL219155A0/en unknown
-
2015
- 2015-06-04 JP JP2015113882A patent/JP6125567B2/ja active Active
- 2015-09-08 US US14/847,966 patent/US10307441B2/en active Active
-
2017
- 2017-04-05 JP JP2017074888A patent/JP2017141275A/ja active Pending
-
2019
- 2019-10-11 US US16/599,710 patent/US20200085861A1/en not_active Abandoned
-
2020
- 2020-06-11 US US16/898,460 patent/US20200297756A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US20200085861A1 (en) | 2020-03-19 |
| AU2010306755B2 (en) | 2015-12-24 |
| CN102686111A (zh) | 2012-09-19 |
| JP2015180674A (ja) | 2015-10-15 |
| AU2010306755A1 (en) | 2012-05-03 |
| JP6125567B2 (ja) | 2017-05-10 |
| CN107260756A (zh) | 2017-10-20 |
| IL219155A0 (en) | 2012-06-28 |
| CA2777066A1 (en) | 2011-04-21 |
| EP2488035B1 (en) | 2017-04-26 |
| CA2777066C (en) | 2020-02-18 |
| JP5758904B2 (ja) | 2015-08-05 |
| WO2011047161A1 (en) | 2011-04-21 |
| JP2017141275A (ja) | 2017-08-17 |
| EP2488035A1 (en) | 2012-08-22 |
| US20160067279A1 (en) | 2016-03-10 |
| US10307441B2 (en) | 2019-06-04 |
| ES2633618T3 (es) | 2017-09-22 |
| EP2488035A4 (en) | 2013-07-31 |
| US10463689B2 (en) | 2019-11-05 |
| US20200297756A1 (en) | 2020-09-24 |
| JP2013508289A (ja) | 2013-03-07 |
| US20110086069A1 (en) | 2011-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2012DN03428A (enExample) | ||
| UA105911C2 (uk) | Сульфонамідні похідні | |
| MX2011008634A (es) | Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia. | |
| GEP20125459B (en) | Compounds for inhibiting mitotic progression | |
| NZ708593A (en) | Novel pyrazole derivative | |
| MX341212B (es) | Inhibidor de bromodominio de benzodiazepina. | |
| GEP20125624B (en) | Pyridazine derivatives as smo inhibitors | |
| IN2012DN01233A (enExample) | ||
| MY152279A (en) | Immediate release pharmaceutical compositions comprising oxycodone and naloxone | |
| EA200971115A1 (ru) | Новые ингибиторы обратной транскриптазы вич | |
| JO3032B1 (ar) | مركبات سبيرو – اوكسندول وإستعمالاتها كعوامل علاجية. | |
| MX2014000341A (es) | Novedosos derivados de trifluoro-metil-oxadiazol y su uso en el tratamiento de enfermedades. | |
| CL2011000504A1 (es) | Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer. | |
| MX2009014235A (es) | 4-bencilaminoquinolonas, composiciones farmaceuticas que las contiene y su uso. | |
| UA105556C2 (uk) | Комбінація сполук, що містить інгібітори віл інтегрази з іншими терапевтичними агентами | |
| MX2010006241A (es) | Derivados de aminotriazol como agonistas de alx. | |
| MX2010009739A (es) | Inhibidores de cinasa pim y metodos para su uso. | |
| MX2010014234A (es) | Compuestos pirazol 436. | |
| MX2011011136A (es) | Eteres diarilicos. | |
| MX2014000130A (es) | Procedimientos y composiciones para la inhibicion de resorcion osea. | |
| PH12013500695A1 (en) | Pharmaceutical compositions containing a dgat1 inhibitor | |
| MX2009011281A (es) | Benzimidazol y composiciones farmaceuticas del mismo. | |
| MX2009004017A (es) | Usos de los compuestos carboxi-amido triazol y sus sales. | |
| UA93709C2 (ru) | 12-имидазолил-1-додеканол и его применение b изготовлении фармацевтических композиций | |
| WO2007143557A3 (en) | Compounds and methods for treating mammalian gastrointestinal parasitic infections |